Acumen Pharmaceuticals (ABOS) Stock Chart & Stock Price History $1.79 +0.02 (+1.13%) (As of 12/24/2024 02:54 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Acumen Pharmaceuticals Stock Price Performance 5 Day Performance-3.24%1 Month Performance-24.15%3 Month Performance-23.50%6 Month Performance-16.36%Year-To-Date Performance-53.39%1 Year Performance-49.86% Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover ABOS Stock Chart for Wednesday, December, 25, 2024 ABOS Chart by TradingView Acumen Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/24/2024$1.77$1.79+1.13%$1.83$1.73363,191 shs$107.54 million12/23/2024$1.85$1.77-4.32%$1.85$1.76781,155 shs$106.34 million12/20/2024$1.80$1.85+2.78%$1.86$1.75995,293 shs$111.15 million12/19/2024$1.79$1.80+0.56%$1.87$1.72366,685 shs$108.14 million12/18/2024$1.96$1.79-8.67%$1.97$1.76355,031 shs$107.54 million12/17/2024$1.97$1.96-0.51%$2.03$1.91348,185 shs$117.76 million Get the Latest News and Ratings for ABOS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/16/2024$2.03$1.97-2.96%$2.02$1.92408,221 shs$118.36 million12/13/2024$2.07$2.03-1.93%$2.09$1.95336,922 shs$121.96 million12/12/2024$2.18$2.07-5.05%$2.24$2.05339,954 shs$124.37 million12/11/2024$2.17$2.18+0.46%$2.24$2.05429,733 shs$130.97 million12/10/2024$2.25$2.17-3.56%$2.23$2.15308,679 shs$130.37 million12/09/2024$2.16$2.25+4.17%$2.29$2.15258,970 shs$135.18 million12/06/2024$2.12$2.16+1.89%$2.19$2.12367,665 shs$129.77 million12/05/2024$2.26$2.12-6.19%$2.27$2.11293,059 shs$127.37 million12/04/2024$2.28$2.26-0.88%$2.35$2.24196,185 shs$135.78 million12/03/2024$2.35$2.28-2.98%$2.41$2.23227,181 shs$136.98 million12/02/2024$2.27$2.35+3.52%$2.41$2.23381,295 shs$141.19 million11/29/2024$2.26$2.27+0.44%$2.31$2.2499,283 shs$136.38 million11/28/2024$2.26$2.26$2.29$2.18304,950 shs$135.78 million11/27/2024$2.20$2.26+2.73%$2.29$2.18304,950 shs$135.78 million11/26/2024$2.36$2.20-6.78%$2.38$2.20322,551 shs$132.18 million11/25/2024$2.37$2.36-0.42%$2.47$2.36179,855 shs$141.79 million Related Companies KALV Stock Chart ANAB Stock Chart ORGO Stock Chart SIGA Stock Chart AURA Stock Chart CDXC Stock Chart AKBA Stock Chart TKNO Stock Chart KRRO Stock Chart ALMS Stock Chart Receive ABOS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acumen Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABOS) was last updated on 12/25/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acumen Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acumen Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
